| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Turning Point Therapeutics, Inc. | SVP & General Counsel | Common Stock | 0 | $76.00 | 17 Aug 2022 | Direct | |
| Turning Point Therapeutics, Inc. | SVP & General Counsel | Stock Option (right to buy) | 0 | 17 Aug 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919122046271-sun-brian-2022-08-17 | Turning Point Therapeutics, Inc. | 17 Aug 2022 | 2 | -$3,420,000 | 4 | SVP & General Counsel | 17 Aug 2022, 16:29 |
| /report/000120919122024214-sun-brian-2022-04-11 | Turning Point Therapeutics, Inc. | 11 Apr 2022 | 2 | $0 | 4 | SVP & General Counsel | 12 Apr 2022, 18:46 |
| /report/000120919122024212-sun-brian-2022-04-11 | Turning Point Therapeutics, Inc. | 11 Apr 2022 | 0 | $0 | 3 | SVP & General Counsel | 12 Apr 2022, 18:44 |